Faulty use of data threatens early intervention for autism
A flawed evaluation process may put programs serving a high proportion of children with autism at risk of funding cuts.
A flawed evaluation process may put programs serving a high proportion of children with autism at risk of funding cuts.
A huge new research collaboration may jump-start the race to develop therapies for autism.
Private equity firms have injected hundreds of millions of dollars into autism therapy companies — and researchers are hopeful this will widen autistic people’s access to care.
A protein proves crucial to spatial memory in mice, genes in the 16p11.2 chromosomal region interact in fruit flies’ eye development, and having more autism features tracks with decreased responsiveness to direct gaze.
Many clinics offer neurofeedback as a therapy for autism, despite little scientific support for the technique.
Researchers can enjoy a complete collection of organoid-related publications, transgenerational effects on the brain are tied to a powerful estrogen, and an app that translates infant cries might aid autism research.
A researcher proposes splitting autism into subtypes, mitochondria make neurotransmitters, and highly successful grantees may face a funding cap.
A 2013 initiative to find biological roots for mental health diagnoses still has broad appeal, but has not produced a dramatic shift in autism research.
Autism researchers are no longer fretting over a shrinking pool of funds for the U.S. National Institutes of Health — at least for the time being.
By the time Ann Marie Owen turned to marijuana to treat her pain, she was struggling to walk and talk. She also hallucinated.